Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Magnus Gisslén and Karin Welén.
Magnus Gisslén
Connection Strength
0.234
Karin Welén
  1. COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 16; 22(1):209.
    View in: PubMed
    Score: 0.234
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.